ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-β copathology

INTRODUCTION: Apolipoprotein E (ApoE) is the most important genetic risk factor for Alzheimer's disease (AD), with ApoE4 thought to enhance and accelerate amyloid-β (Aβ) pathology. ApoE4 has recently been described to increase neurodegeneration in a mouse model of frontotemporal dementia (FTD),...

Descripción completa

Detalles Bibliográficos
Autores principales: Koriath, Carolin, Lashley, Tammaryn, Taylor, William, Druyeh, Ronald, Dimitriadis, Athanasios, Denning, Nicola, Williams, Julie, Warren, Jason D., Fox, Nick C., Schott, Jonathan M., Rowe, James B., Collinge, John, Rohrer, Jonathan D., Mead, Simon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430720/
https://www.ncbi.nlm.nih.gov/pubmed/30949567
http://dx.doi.org/10.1016/j.dadm.2019.01.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430720/
https://www.ncbi.nlm.nih.gov/pubmed/30949567
http://dx.doi.org/10.1016/j.dadm.2019.01.010

Ejemplares similares